Skip to Main Content

Paper Details

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Ann Oncol
41
2023
HER2, HER2-low breast cancer, Human, Human epidermal growth factor receptor 2, Human epidermal growth factor receptor 2 (HER2)-low breast cancer, anti-HER2, breast cancer, breast tumors, metastatic breast cancer, patients
Author NameAffiliation
Michael F PressNorris Comprehensive Cancer Center, University of Southern California
Aditya BardiaHarvard Medical School, Massachusetts General Hospital
Lisa A CareyLineberger Comprehensive Cancer Center, University of North Carolina
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Sara M TolaneyDana-Farber Cancer Institute, Boston Harvard Medical School
Antonio C WolffThe Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Giuseppe CuriglianoUniversity of Milan, Milan European Institute of Oncology, IRCCS
  • 1 - 7

Datasets

Release 1.2